Comprehensive Therapy

, Volume 29, Issue 2–3, pp 108–114 | Cite as

Management of actic keratoses

  • Pearon G. LangJr.
Original Article
  • 8 Downloads

Abstract

Actinic keratoses are quite common. Since they represent the initial stage in the evolution of squamous cell carcinoma, recognition and treatment are important. Recently, new treatment modalities have become available including immune modulators, photodynamic therapy, and topical nonsteroidal anti-inflammatory agents.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Stockfleth E, Meyer T, Benninghoff B, et al. Successful treatment of actinic keratosis with imiquimod cream 5%: A report of six cases. Br J Dermatol. 2001;144:1050–3.PubMedCrossRefGoogle Scholar
  2. 2.
    Frost CA, Green AC. Epidemiology of solar keratoses. Br J Dermatol. 1994;131:455–64.PubMedCrossRefGoogle Scholar
  3. 3.
    Lober BA, Lober CW. Actinic keratosis is squamous cell carcinoma. South Med J. 2000;7:650–5.Google Scholar
  4. 4.
    Engel A, Johnson ML, Haynes SG. Health effects of sunlight exposure in the United States: Results from the first national health and nutrition examination survey 1971–4. Arch. Dermatol. 1988;124:72–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42:S4-S7.CrossRefGoogle Scholar
  6. 6.
    Moy RL. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42:S8-S10.CrossRefGoogle Scholar
  7. 7.
    Schwartz RA. The actinic keratosis: A perspective and update. Dermatol Surg. 1997;23:1009–19.PubMedCrossRefGoogle Scholar
  8. 8.
    Jeffes EWB III, Tang EH. Actinic keratosis. Current treatment options. Am J Clin Dermatol. 2002;3:167–79.Google Scholar
  9. 9.
    Bavinck JN, DeBoer A, Vermeer BJ, et al. Sunlight, keratotic skin lesions, and skin cancer in renal transplant recipients. Br J Dermatol. 1993;129:242–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Tucci MG, Offidani A, Lucarini G, et al. Advances in the understanding of malignant transformation of keratinocytes: An immunohistochemical study. J Eur Acad Dermatol Venereol. 1998;10:118–24.PubMedCrossRefGoogle Scholar
  11. 11.
    Van Praag MC, Bavinick JN, Bergman W, et al. PUVA keratosis. A clinical and histopathologic entity associated with an increased risk of non-melanoma skin cancer. J Am Acad Dermatol. 1993;28:412–7.PubMedGoogle Scholar
  12. 12.
    Wolf JE Jr, Taylor JR, Tschen E, et al. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol. 2001;40:709–13.PubMedCrossRefGoogle Scholar
  13. 13.
    Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol. 2000;42:S23-S24.CrossRefGoogle Scholar
  14. 14.
    Dobson JM, DeSpain J, Hewett JE, et al. Malignant potential of actinic keratoses and controversy over treatment: A patient-oriented perspective. Arch Dermatol. 1991;127:1029–31.CrossRefGoogle Scholar
  15. 15.
    Cockrell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma (actinic keratosis). J Am Acad Dermatol. 2000;42:S11-S17.CrossRefGoogle Scholar
  16. 16.
    Ziegler A, Jonason AS, Lefell DJ, et al. Sunburn and p53 in the onset of skin cancer. Nature. 1994;372:773–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Nelson MA, Eiknspahr JG, Alberto DS, et al. Analysis of p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett. 1991;85:23–9.CrossRefGoogle Scholar
  18. 18.
    Marks R, Ronnie G, Selwood TS. Malignant transformation of solar keratosis to squamous cell carcinoma. Lancet. 1988; I:795–7.CrossRefGoogle Scholar
  19. 19.
    Farmer KC, Naylor MF. Sun exposure, sunscreens, and skin cancer prevention: A year round concern. Ann Pharmacother. 1996;30:662–73.PubMedGoogle Scholar
  20. 20.
    Marks R, Motley RJ. Skin cancer: recognition and treatment. Drugs. 1995;50:48–61.PubMedGoogle Scholar
  21. 21.
    Marks R, Foley P, Goodman G, et al. Spontaneous reminsion of solar keratosis: The case for conservative management. Br J Dermatol. 1986;115:649–55.PubMedCrossRefGoogle Scholar
  22. 22.
    Dinehart SM. The treatment of actinic keratoses. J Am Acad Dermatol. 2000;42:S25-S28.CrossRefGoogle Scholar
  23. 23.
    Lubritz RR, Smolewski SA. Cryosurgery cure rate of actinic keratoses. J Am Acad Dermatol. 1982;7:631–2.PubMedGoogle Scholar
  24. 24.
    Chiarello SE. Cryopeeling (extensive cryosurgery) for treatment of actinic keratoses. An update and comparison. Dermatol Surg. 2000;8:728–32.CrossRefGoogle Scholar
  25. 25.
    Schwartz RA. Therapeutic perspective in actinic and other keratoses. Int J Dermatol. 1996;35:533–8.PubMedGoogle Scholar
  26. 26.
    Kuflik EG. Cryosurgery updated. J Am Acad Dermatol. 1994;31:925–34.PubMedCrossRefGoogle Scholar
  27. 27.
    Goette DK. Topical chemotherapy with 5 fluoracil. A review. J Am Acad Dermatol. 1981;4:633–49.PubMedGoogle Scholar
  28. 28.
    Robinson TA, Kligman AM. Treatment of solar keratoses of the extremities with retinoic acid and 5-flurouracil. Br J Dermatol. 1975;92:703–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Bercovitch L. Topical chemotherapy of actinic keratoses of the upper extremity with tretinoin and 5-flurouracil: A double-blind controlled study. Br J Dermatol. 1987;116:549–52.PubMedCrossRefGoogle Scholar
  30. 30.
    Epstein E. Does intermittent pulse topical 5 flurouracil therapy allow destruction of actinic keratoses without significant inflammation J Am Acad Dermatol. 1998;38:77–80.PubMedCrossRefGoogle Scholar
  31. 31.
    Lawrence N, Cox SE, Clay J, et al. A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluoracil in the treatment of widespreac facial actinic keratoses. Arch Dermatol. 1995;131:176–81.PubMedCrossRefGoogle Scholar
  32. 32.
    Coleman WP, Yarborough JM, Mandy SH, Dermabrasion for prophylaxis and treatment of actinic keratosis. Dermatol. Surg. 1996;22:17–21.PubMedCrossRefGoogle Scholar
  33. 33.
    Fitzpatrick R, Goldman MP, Satur NM, et al. Pulsed carbon dioxide laser resurfacing of photo damaged skin. Arch Dermatol. 1996;132:395–402.PubMedCrossRefGoogle Scholar
  34. 34.
    Spicer MS, Goldberg DJ. Lasers in dermatology. J Am Acad Dermatol. 1996;34:1–25.PubMedCrossRefGoogle Scholar
  35. 35.
    Jeffes EWB, McCullough JL, Weinstein GD, et al. Photodynamic therapy of actinic keratoses with topical 5-aminolevulonic acid. A pilot dose-ranging study. Arch Dermatol. 1997; 133:727–32.PubMedCrossRefGoogle Scholar
  36. 36.
    Kurwa HA, Yong-Gee SA, Seed PT, et al. A randomized paired comparison of photodynamic therapy and topical 5-flurouracil in the treatment of actinic keratosis. J Am Acad Dermatol. 1999;41:414–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Beutner KR, Geisse JK, Helman D, et al. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol. 1999; 41:1002–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Rivers JK, McLean DI. An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses. Arch Dermatol. 1997;133:1239–42.PubMedCrossRefGoogle Scholar
  39. 39.
    Peters DC, Foster RH. Diclofenac/hyaluronic acid. Drugs Aging. 1999;14:313–21.PubMedCrossRefGoogle Scholar
  40. 40.
    Dufresne RG, Curlin MU. Actinic cheilitis: a treatment review. Dermatol Surg. 1997;23:15–21.PubMedCrossRefGoogle Scholar
  41. 41.
    Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl Med J. 1993;329: 1147–51.CrossRefGoogle Scholar
  42. 42.
    Naylor MF, Boyd A, Smith DW, et al. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol. 1995;131:170–5.PubMedCrossRefGoogle Scholar
  43. 43.
    Kligman AM, Thorne EG. Topical therapy of actinic keratoses with tretino. In: Marks R, ed. Retinoids in Cutaneous Malignancy. Oxford, Blackwell Scientific Publications; 1991:66–73.Google Scholar

Copyright information

© Humana Press Inc. 2003

Authors and Affiliations

  • Pearon G. LangJr.
    • 1
  1. 1.Department of DermatologyMedical University of South CarolinaCharlestonUSA

Personalised recommendations